CYGNOS BIOTECH, LLC

Capabilities

CYGNOS BioTech, LLC is a U.S.–based small business biotechnology company specializing in the development of virus-agnostic, host-directed antiviral biologics for veterinary and future human use, aligned with One Health and biodefense priorities. The company applies protein biologic engineering, advanced analytical characterization, and AI-assisted structural modeling to enable safe, manufacturable antiviral candidates. CYGNOS leverages an integrated network of academic, CRO, and cGMP manufacturing partners to advance programs from early discovery through preclinical development, regulatory engagement, and pilot clinical evaluation.